UCB - Current Liabilities



UCB reported EUR3.53B in Current Liabilities for its fiscal semester ending in December of 2024.


Current Liabilities Change Date
Alcon AG USD 2.42B 178M Jun/2025
Almirall EUR 298.52M 36.18M Jun/2025
Amarin USD 162.41M 17.54M Mar/2025
argenx SE 1.04B 371.99M Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Galapagos EUR 402.95M 34.09M Jun/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
GRIFOLS EUR 1.99B 180.07M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 9.86B 357M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Orion EUR 540.8M 254.6M Jun/2025
Recordati EUR 1.07B 82.43M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
UCB EUR 3.53B 731M Dec/2024
Unibail Rodamco EUR 5.17B 181.4M Dec/2024